WebFXIa Inhibitor (BMS-986209) 1 Small Molecule n ROMK Inhibitor 1 Small Molecule Cardiac myosin inhibitor 1 Small Molecule n danicamtiv 2 Small Molecule n FA-Relaxin 2 … WebMar 29, 2024 · The purpose of this study is to assess the safety, tolerability, and single-dose pharmacokinetics of danicamtiv in healthy Japanese and Caucasian participants. ... Name: BMS Study Connect Contact Center www.BMSStudyConnect.com; Phone Number: 855-907-3286; Email: [email protected]
Bristol Myers Squibb - Bristol Myers Squibb Completes ... - BMS …
WebApr 10, 2024 · A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Danicamtiv in Healthy Japanese and Caucasian Participants Anticipated Study Start Date : WebBET Inhibitor (BMS-986158) – Hematologic Malignancies REVLIMID – 1L Multiple Myeloma – Mantle Cell Lymphoma – MDS – Multiple Myeloma – Previously treated Follicular Lymphoma – Relapsed/Refractory Adult T-cell Leukemia/Lymphoma ... danicamtiv – Genetic Dilated Cardiomyopathy helline relais
Pipeline Clinical Trials BMS Science HCP Site
WebMarch 2024. Partnership with bluebird bio results in FDA approval of Abecma (idecabtagene vicleucel), the first anti-BCMA CAR T cell therapy for relapsed or refractory multiple … WebUniquely, danicamtiv preserves the detachment (relaxation) steps of the actin–myosin chemo-mechanical cycle, and has been shown not to affect end-diastolic stiffness (in … WebIn addition to oHCM, BMS is also set to explore the potential of mavacamten in additional indications, including non-obstructive HCM. On top of mavacamten, BMS is developing … hellingtrekken automaat